(ii)
the use of the investigational medicinal products is evidence-based and supported by published scientific evidence on the safety and efficacy of those investigational medicinal products in any of the Member States concerned; and
← art_2__para_2__point_3__point_b__point_i__text_1 · All articles · art_2__para_2__point_3__point_b__point_ii__text_1 →
Source: EUR-Lex (Cellar) · retrieved 2026-11-06 · Text as adopted (Official Journal); later amendments are not incorporated in this text.